Rigel Pharmaceuticals (RIGL)

Add to Watchlists
Create an Alert
3.18 -0.01  -0.31% NASDAQ Jun 22, 20:00 Delayed 2m USD

Rigel Pharmaceuticals Price to Book Value:

6.518 for June 22, 2018
View 4,000+ financial data types
Browse...
View Full Chart

Rigel Pharmaceuticals Price to Book Value Chart

Export Data
Save Image
Print Image

Rigel Pharmaceuticals Historical Price to Book Value Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 22, 2018 6.518
June 21, 2018 6.538
June 20, 2018 6.477
June 19, 2018 6.436
June 18, 2018 6.498
June 15, 2018 6.559
June 14, 2018 6.744
June 13, 2018 6.744
June 12, 2018 6.764
June 11, 2018 6.60
June 8, 2018 7.276
June 7, 2018 7.215
June 6, 2018 7.768
June 5, 2018 7.727
June 4, 2018 7.051
June 1, 2018 6.662
May 31, 2018 6.662
May 30, 2018 6.805
May 29, 2018 7.543
May 25, 2018 8.014
May 24, 2018 8.096
May 23, 2018 8.096
May 22, 2018 8.117
May 21, 2018 8.137
May 18, 2018 8.322
   
May 17, 2018 8.158
May 16, 2018 8.137
May 15, 2018 8.014
May 14, 2018 8.055
May 11, 2018 7.973
May 10, 2018 7.584
May 9, 2018 7.707
May 8, 2018 7.522
May 7, 2018 7.830
May 4, 2018 7.932
May 3, 2018 7.994
May 2, 2018 7.789
May 1, 2018 7.584
April 30, 2018 7.399
April 27, 2018 7.461
April 26, 2018 7.481
April 25, 2018 6.814
April 24, 2018 6.888
April 23, 2018 6.648
April 20, 2018 7.091
April 19, 2018 7.497
April 18, 2018 7.165
April 17, 2018 7.589
April 16, 2018 6.888
April 13, 2018 7.294

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Advertisement

RIGL Price to Book Value Benchmarks

Benchmarks
Bio-Path Holdings 2.899
Catabasis Pharmaceuticals 2.043
Aeglea BioTherapeutics 5.335

RIGL Price to Book Value Range, Past 5 Years

Minimum 0.9197 Dec 18 2013
Maximum 11.22 Nov 27 2017
Average 3.389

RIGL Price to Book Value Excel Add-In Codes

  • Metric Code: price_to_book_value
  • Latest data point: =YCP("RIGL", "price_to_book_value")
  • Last 5 data points: =YCS("RIGL", "price_to_book_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.